Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury

Brain Injury

Volumn 26, Issue 13-14, 2012, Pages 1629-1635

  Mondello, Stefania ^a,b   Gabrielli, Andrea ^b   Catani, Sheila ^c   D'Ippolito, Mariagrazia ^c   Jeromin, Andreas ^a   Ciaramella, Antonio ^c   Bossù, Paola ^c   Schmid, Kara ^d   Tortella, Frank ^d   Wang, Kevin K W ^a,b   Hayes, Ronald L ^a,b   Formisano, Rita ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b BANYAN BIOMARKERS INC   (United States)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Biomarkers; Cognitive functioning; MAP2; Outcome; Traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; MICROTUBULE ASSOCIATED PROTEIN 2; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COGNITION; CONSCIOUSNESS; DENDRITE; DIFFUSE AXONAL INJURY; DISABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALLING; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE EXTENDED; HUMAN; LABORATORY TEST; LEVELS OF COGNITIVE FUNCTIONING SCALE; MALE; NERVE CELL; NERVE CELL PLASTICITY; NERVE REGENERATION; NEUROIMAGING; OUTCOME ASSESSMENT; PERSISTENT VEGETATIVE STATE; PROTEIN BLOOD LEVEL; RANCHO LOS AMIGOS SCALE; RATING SCALE; SERUM; SURVIVOR; TRAFFIC ACCIDENT; TRAUMATIC BRAIN INJURY;

EID: 84869383633     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2012.700083     Document Type: Article

References (36)

1. Polinder S, Meerding WJ, Mulder S, Petridou E, van Beeck E. EUROCOST Reference Group. Assessing the burden of injury in six European countries. Bulletin of the World Health Organization 2007;85:27-34. (Pubitemid 46105324)
2. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: A public health perspective. Journal of Head Trauma Rehabilitation 1999;14: 602-615. (Pubitemid 30027268)
3. Kampfl A, Schmutzhard E, Franz G, Pfausler B, Haring HP, Ulmer H, Felber S, Golaszewski S, Aichner F. Prediction of recovery from post-traumatic vegetative state with cerebral magnetic-resonance imaging. Lancet 1998;351:1763-1767. (Pubitemid 28269186)
4. Formisano R, Carlesimo GA, Sabbadini M, Loasses A, Penta F, Vinicola V, Caltagirone C. Clinical predictors and neuropsychological outcome in severe traumatic brain injury patients. Acta Neurochirurgica 2004;146:457-462. (Pubitemid 38649427)
5. Logi F, Fischer C, Murri L, Mauguiere F. The prognostic value of evoked responses from primary somatosensory and auditory cortices in comatose patients. Clinical Neurophysiology 2003;114:1615-1627. (Pubitemid 37028314)
6. Urrea C, Castellanos DA, Sagen J, Tsoulfas P, Bramlett HM, Dietrich WD. Widespread cellular proliferation and focal neurogenesis after traumatic brain injury in the rat. Restorative Neurology and Neuroscience 2007;25:65-76. (Pubitemid 46631014)
7. Wagner AK, Zitelli KT. A Rehabilomics focused perspective on molecular mechanisms underlying neurological injury, complications, and recovery after severe TBI. Pathophysiology 2012; [Epub ahead of print].
8. Avila J. Microtubule function. Life Sciences 1992;50: 327-334.
9. Drewes G, Ebneth A, Mandelkow EM. MAPs, MARKs and microtubule dynamics. Trends in Biochemical Sciences 1998;23:307-311.
10. Maccioni RB, Cambiazo V. Role of microtubule-associated proteins in the control of microtubule assembly. Physiological Review 1995;75:835-864.
11. Johnson GVW, Jope RS. The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration. Journal of Neuroscience Research 1992;33: 505-512.
12. Kitagawa K, Matsumoto M, Ninobe M, Mikoshiba K, Hata R, Ueda H, Handa N, Fukunaga R, Isaka Y, Kimura K, Kamada T. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage- immunohistochemical investigation of dendritic damage. Neuroscience 1989;31:401-411. (Pubitemid 19238646)
13. Posmantur RM, Kampfl A, Taft WC, Bhattacharjee M, Dixon CE, Bao J, Hayes RL. Diminished microtubuleassociated protein 2 (MAP2) immunoreactivity following cortical impact brain injury. Journal of Neurotrauma 1996;13:125-137. (Pubitemid 26104497)
14. Park D, Joo SS, Lee HJ, Choi KC, Kim SU, Kim YB. Microtubule-associated protein 2, an early blood marker of ischemic brain injury. Journal of Neuroscience Research 2012;90:461-467.
15. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81-84.
16. Trauma Foundation Brain. Guidelines for the Management of Severe Traumatic Brain Injury. Journal of Neurotrauma 2007;24(Suppl 1):S1-S95.
17. Hagen C, Malkmus D, Durham P. Levels of cognitive functioning. In: Rehabilitation of the head injured adult. Comprehensive physical management. Downey, CA: Professional Staff Association of Rancho Los Amigos Hospital, Inc.; 1979.
18. Multi-Society Task Force on The, PVS. Medical aspects of the persistent vegetative state. New England Journal of Medicine 1994;330:1499-1508.
19. Giacino JT, Ashwal S, Childs N, Cranford R, Jennett B, Katz DI, Kelly JP, Rosenberg JH, Whyte J, Zafonte RD, et al. The minimally conscious state: Definition and diagnostic criteria. Neurology 2002;58:349-353. (Pubitemid 34150906)
20. Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: Guidelines for their use. Journal of Neurotrauma 1998;15:573-585.
21. Masliah E, Terry R. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathology 1993;3:77-85. (Pubitemid 23046378)
22. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology 1991;30:572-580.
23. Morales M, Fifkova E. Distribution of MAP2 in dendritic spines and its colocalization with actin. An immunogold electron-micoscope study. Cell and Tissue Research 1989;256:447-456.
24. Greenough WT, Bailey CH. The anatomy of a memory. Trends in Neuroscience 1987;11:142-147.
25. De Camilli P, Miller PE, Navone F, Theurkauf WE, Vallee RB. Distribution of microtubule-associated protein 2 in the nervous system of the rat studied by immunolluorescence. Neuroscience 1984;11:817-846.
26. Huber G, Matus A. Differences in the cellular distribution of two microtubule-associated proteins, MAP1 and MAP2, in rat brain. Journal of Neuroscience 1984;4:151-160. (Pubitemid 14198296)
27. Caceres A, Payne MR, Binder LI, Steward O. Immunocytochemical localization of actin and microtubuleassociated protein MAP2 in dendritic spines. Proc Natl Acad Sci USA 1983;80:1738-1742. (Pubitemid 13136423)
28. Morales M, Fifkova E. Distribution of MAP2 in dendritic spines and its colocalization with actin. An immunogold electron-micoscope study. Cell and Tissue Research 1989;256:447-456.
29. Greenough WT, Bailey CH. The anatomy of a memory. Trends in Neuroscience 1987;11:142-147.
30. Bailey CH, Kandel ER. Structural changes accompanying memory storage. Annual Review of Physiology 1993;55: 397-426. (Pubitemid 23102139)
31. Strens LH, Mazibrada G, Duncan JS, Greenwood R. Misdiagnosing the vegetative state after severe brain injury: The influence of medication. Brain Injury 2004;18:213-218. (Pubitemid 38232716)
32. Schnakers C, Vanhaudenhuyse A, Giacino J, Ventura M, Boly M, Majerus S, Moonen G, Laureys S. Diagnostic accuracy of the vegetative and minimally conscious state: Clinical consensus versus standardized neurobehavioral assessment. BMC Neurology 2009;21:9-35.
33. Gosseries O, Bruno MA, Chatelle C, Vanhaudenhuyse A, Schnakers C, Soddu A, Laureys S. Disorders of consciousness: What's in a name? NeuroRehabilitation 2011;28:3-14.
34. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossmann T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: Relationship to IL-6, TNFalpha, TGF-beta1 and bloodbrain barrier function. Journal of Neuroimmunology 1999;101:211-221. (Pubitemid 29516464)
35. Blyth BJ, Farhavar A, Gee C, Hawthorn B, He H, Nayak A, Stöcklein V, Bazarian JJ. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. Journal of Neurotrauma 2009;26:1497-1507.
36. Blyth BJ, Farahvar A, He H, Nayak A, Yang C, Shaw G, Bazarian JJ. Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury. Journal of Neurotrauma 2011;28:2453-2462.